@ARTICLE{
author={Vukovic Petar G,Jeremic Aleksandra,Vezmar Milica,Milosavljevic Filip,Pavlovic Zorana Z,Pesic Danilo R,Drakulic-Djordjevic Jelena,Pejuskovic Bojana,Markovic Bojan D,Ingelman-Sundberg Magnus,Miljevic Cedo D,Maric Nadja P,Jukic Marin M},
year={2026},
title={Perceived stress four weeks after initiation of escitalopram monotherapy as a predictor of anxiolytic and antidepressant effects},
journal={JOURNAL OF AFFECTIVE DISORDERS},
volume={403},
number={},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Vukovic Petar G,Jeremic Aleksandra,Vezmar Milica,Milosavljevic Filip,Pavlovic Zorana Z,Pesic Danilo R,Drakulic-Djordjevic Jelena,Pejuskovic Bojana,Markovic Bojan D,Ingelman-Sundberg Magnus,Miljevic Cedo D,Maric Nadja P,Jukic Marin M},
year={2025},
title={Effectiveness and safety of escitalopram treatment personalized based on therapeutic drug monitoring of drug plasma concentration: a prospective cohort study},
journal={SCIENTIFIC REPORTS},
volume={15},
number={1},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Van Riet Sander,Julien Anais,Atanasov Andrea,Nordling Asa,Ingelman-Sundberg Magnus},
year={2024},
title={The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH model},
journal={HEPATOLOGY COMMUNICATIONS},
volume={8},
number={3},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Van Riet Sander,Julien Anais,Atanasov Andrea,Nordling Asa,Ingelman-Sundberg Magnus},
year={2024},
title={The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH model},
journal={HEPATOLOGY COMMUNICATIONS},
volume={8},
number={3},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Ingelman-Sundberg Magnus,Jukic Marin M,Braten Line Skute,Kringen Marianne Kristiansen,Molden Espen},
year={2024},
title={What is the Current Clinical Impact of the CYP2CTG Haplotype?},
journal={CLINICAL PHARMACOLOGY & THERAPEUTICS},
volume={115},
number={2},
pages={183-183},
document_type={Letter},
} 

@ARTICLE{
author={Lenk Hasan Cagin,Lovsletten Smith Robert,O'Connell Kevin S,Jukic Marin M,Kringen Marianne Kristiansen,Andreassen Ole A,Ingelman-Sundberg Magnus,Molden Espen},
year={2023},
title={Impact of NFIB and CYP1A variants on clozapine serum concentration-A retrospective naturalistic cohort study on 526 patients with known smoking habits},
journal={CTS-CLINICAL AND TRANSLATIONAL SCIENCE},
volume={16},
number={1},
pages={62-72},
document_type={Article},
} 

@ARTICLE{
author={Jukic Marin M,Milosavljevic Filip,Molden Espen,Ingelman-Sundberg Magnus},
year={2022},
title={Pharmacogenomics in treatment of depression and psychosis: an update},
journal={TRENDS IN PHARMACOLOGICAL SCIENCES},
volume={43},
number={12},
pages={1055-1069},
document_type={Review},
} 

@ARTICLE{
author={Braten Line Skute,Ingelman-Sundberg Magnus,Jukic Marin M,Molden Espen,Kringen Marianne Kristiansen},
year={2022},
title={Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population},
journal={CTS-CLINICAL AND TRANSLATIONAL SCIENCE},
volume={15},
number={9},
pages={2135-2145},
document_type={Article},
} 

@ARTICLE{
author={Pridgeon Chris S,Bolhuis Dian P,Milosavljevic Filip,Manojlovic Marina,Vegvari Akos,Gaetani Massimiliano,Jukic Marin M,Ingelman-Sundberg Magnus},
year={2022},
title={Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids},
journal={CELLS},
volume={11},
number={10},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Lenk Hasan Cagin,Kloditz Katharina,Johansson Inger,Smith Robert Lovsletten,Jukic Marin M,Molden Espen,Ingelman-Sundberg Magnus},
year={2022},
title={The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients},
journal={CLINICAL PHARMACOLOGY & THERAPEUTICS},
volume={111},
number={5},
pages={1165-1174},
document_type={Article},
} 

@ARTICLE{
author={Jukic Marin M,Smith Robert Lovsletten,Molden Espen,Ingelman-Sundberg Magnus},
year={2021},
title={Evaluation of the CYP2D6 Haplotype Activity Scores Based on Metabolic Ratios of 4,700 Patients Treated With Three Different CYP2D6 Substrates},
journal={CLINICAL PHARMACOLOGY & THERAPEUTICS},
volume={110},
number={3},
pages={750-758},
document_type={Article},
} 

@ARTICLE{
author={Braten Line Skute,Haslemo Tore,Jukic Marin M,Ivanov Maxim,Ingelman-Sundberg Magnus,Molden Espen,Kringen Marianne Kristiansen},
year={2021},
title={A Novel CYP2C-Haplotype Associated With Ultrarapid Metabolism of Escitalopram},
journal={CLINICAL PHARMACOLOGY & THERAPEUTICS},
volume={110},
number={3},
pages={786-793},
document_type={Article},
} 

@ARTICLE{
author={Smith Robert Lovsletten,Tveito Marit,Kylleso Lennart,Jukic Marin M,Ingelman-Sundberg Magnus,Andreassen Ole A,Molden Espen},
year={2021},
title={Rates of complete nonadherence among atypical antipsychotic drugs: A study using blood samples from 13,217 outpatients with psychotic disorders},
journal={SCHIZOPHRENIA RESEARCH},
volume={228},
number={},
pages={590-596},
document_type={Article},
} 

@ARTICLE{
author={Milosavljevic Filip,Bukvic Nikola,Pavlovic Zorana Z,Miljevic Cedo D,Pesic Vesna,Molden Espen,Ingelman-Sundberg Magnus,Leucht Stefan,Jukic Marin M},
year={2021},
title={Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure A Systematic Review and Meta-analysis},
journal={JAMA PSYCHIATRY},
volume={78},
number={3},
pages={270-280},
document_type={Review},
} 

@ARTICLE{
author={Milosavljevic Filip,Bukvic Nikola,Pavlovic Zorana Z,Miljevic Cedo D,Pesic Vesna,Molden Espen,Ingelman-Sundberg Magnus,Leucht Stefan,Jukic Marin M},
year={2020},
title={Impact of CYP2C19 and CYP2D6 polymorphism on antidepressants and antipsychotics exposure; a meta-analysis},
journal={EUROPEAN NEUROPSYCHOPHARMACOLOGY},
volume={40},
number={},
pages={S250-S251},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Milosavljevic Filip,Vucic Marija,Manojlovic M,Milosevski T,Batinic Bojan A,Novalen M,Miksys S,Tyndale FR,Ingelman-Sundberg Magnus,Pesic Vesna,Jukic Marin M},
year={2020},
title={Reduced cerebellum volume and ataxia-like motoric phenotype in transgenic mouse, carrier of human CYP2C19 gene},
journal={EUROPEAN NEUROPSYCHOPHARMACOLOGY},
volume={40},
number={},
pages={S208-S208},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Smith Robert Lovsletten,Tveito Marit,Kylleso Lennart,Jukic Marin M,Ingelman-Sundberg Magnus,Andreassen Ole A,Molden Espen},
year={2020},
title={Impact of antipsychotic polypharmacy on nonadherence of oral antipsychotic drugs & ndash; A study based on blood sample analyses from 24,239 patients},
journal={EUROPEAN NEUROPSYCHOPHARMACOLOGY},
volume={37},
number={},
pages={64-69},
document_type={Article},
} 

@ARTICLE{
author={Van Westrenhen Roos,Aitchison Katherine J,Ingelman-Sundberg Magnus,Jukic Marin M},
year={2020},
title={Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?},
journal={FRONTIERS IN PSYCHIATRY},
volume={11},
number={},
pages={-},
document_type={Review},
} 

@ARTICLE{
author={Braten Line Skute,Haslemo Tore,Jukic Marin M,Ingelman-Sundberg Magnus,Molden Espen,Kringen Marianne Kristiansen},
year={2020},
title={Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients},
journal={NEUROPSYCHOPHARMACOLOGY},
volume={45},
number={3},
pages={570-576},
document_type={Article},
} 

@ARTICLE{
author={Milosavljevic Filip,Bukvic Nikola,Pesic Vesna,Molden Espen,Ingelman-Sundberg Magnus,Jukic Marin M},
year={2019},
title={Quantification of antidepressant and antipsychotic exposure increase caused by CYP2C19 and CYP2D6 intermediate and poor metabolizer status by meta-analysis},
journal={EUROPEAN NEUROPSYCHOPHARMACOLOGY},
volume={29},
number={},
pages={S533-S534},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Milosavljevic Filip,Vucic Marija,Manojlovic M,Asujic N,Batinic Bojan A,Novalen M,Miksys S,Tyndale RF,Ingelman-Sundberg Magnus,Jukic Marin M},
year={2019},
title={Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia},
journal={EUROPEAN NEUROPSYCHOPHARMACOLOGY},
volume={29},
number={},
pages={S399-S400},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Milosavljevic Filip,Vucic Marija,Manojlovic M,Asujic N,Batinic Bojan A,Novalen M,Miksys S,Tyndale RF,Ingelman-Sundberg Magnus,Pesic Vesna,Jukic Marin M},
year={2019},
title={Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia},
journal={EUROPEAN NEUROPSYCHOPHARMACOLOGY},
volume={29},
number={},
pages={S17-S17},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Jukic Marin M,Smith Robert Lovsletten,Haslemo Tore,Molden Espen,Ingelman-Sundberg Magnus},
year={2019},
title={Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study},
journal={LANCET PSYCHIATRY},
volume={6},
number={5},
pages={418-426},
document_type={Article},
} 

@ARTICLE{
author={Milosavljevic Filip,Vucic Marija,Manojlovic M,Asujic N,Batinic Bojan A,Novalen M,Miksys S,Tyndale RF,Ingelman-Sundberg Magnus,Pesic Vesna,Jukic Marin M},
year={2019},
title={Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia},
journal={EUROPEAN NEUROPSYCHOPHARMACOLOGY},
volume={29},
number={},
pages={S672-S673},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Haslemo Tore,Eliasson Erik,Jukic Marin M,Ingelman-Sundberg Magnus,Molden Espen},
year={2019},
title={Significantly lower CYP2D6 metabolism measured as the O/N-desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients},
journal={BRITISH JOURNAL OF CLINICAL PHARMACOLOGY},
volume={85},
number={1},
pages={194-201},
document_type={Article},
} 

@ARTICLE{
author={Jukic Marin M,Lauschke Volker M,Saito Takahiro,Hiratsuka Masahiro,Ingelman-Sundberg Magnus},
year={2018},
title={Functional characterization of CYP2D7 gene variants},
journal={PHARMACOGENOMICS},
volume={19},
number={12},
pages={931-936},
document_type={Article},
} 

@ARTICLE{
author={Jukic Marin M,Haslemo Tore,Molden Espen,Ingelman-Sundberg Magnus},
year={2018},
title={Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients},
journal={AMERICAN JOURNAL OF PSYCHIATRY},
volume={175},
number={5},
pages={463-470},
document_type={Article},
} 

@ARTICLE{
author={Aklillu Eleni,Djordjevic Natasa D,Carrillo Juan Antonio,Makonnen Eyasu,Bertilsson Leif,Ingelman-Sundberg Magnus},
year={2014},
title={High CYP2A6 Enzyme Activity as Measured by a Caffeine Test and Unique Distribution of CYP2A6 Variant Alleles in Ethiopian Population},
journal={OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY},
volume={18},
number={7},
pages={446-453},
document_type={Article},
}